Surgical details and complication rates of bilateral salpingo-oophorectomy in the study cohort
| n | % | |
| All BSO | 234 | |
| Admission | ||
| Inpatient | 33 | 14.7 |
| Outpatient | 192 | 85.3 |
| Surgery type | ||
| Laparoscopy | 152 | 66.7 |
| Laparotomy | 14 | 6.1 |
| Robotic | 62 | 27.2 |
| Concomitant surgery | 89 | 38.9 |
| Breast surgery | 46 | 20.1 |
| Hysterectomy | 35 | 15.3 |
| Other surgery | 24 | 10.5 |
| BSO with and without concomitant surgery (n=234) | ||
| Readmission | 4 | 1.8 |
| Complications | 12 | 5.4 |
| Surgery duration (min) | ||
| Median (mean) | 95 (112.1) | |
| Range | 18–647 | |
| IQR | 53.2–145.8 | |
| EBL (mL) | ||
| Median (mean) | 20 (41.5) | |
| Range | 0–1000 | |
| IQR | ||
| Hospitalization (days) | ||
| Median (mean) | 0 (0.5) | |
| Range | 0–7 | |
| IQR | 0–0 | |
| Comorbidity* | 52 | 23.3 |
| BSO without concomitant surgery (n=145) | ||
| Readmission | 1 | 0.7 |
| Complications | 2 | 1.5 |
| Surgery duration (min) | ||
| Median (mean) | 62 (71.4) | |
| Range | 18–185 | |
| IQR | 40–92 | |
| EBL (mL) | ||
| Median (mean) | 20 (24.8) | |
| Range | 0–300 | |
| IQR | ||
| Hospitalization (days) | ||
| Median (mean) | 0 (0.1) | |
| Range | 0–1 | |
| IQR | 0–0 | |
| Comorbidity* | 32 | 23.7 |
Missing variables are not included in the percentage denominators.
*Comobidity includes at least one incidence of ‘hypothyroidism’, ‘arterial hypertension’, ‘heart disease’, ‘pulmonary embolism or DVT’ or ‘diabetes’.
BSO, bilateral salpingo-oophorectomy; EBL, estimated blood loss; IQR, interquartile range.